- Home
- SWBI vs NPCE Comparison
SWBI vs NPCE Comparison
Compare SWBI & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWBI
- NPCE
- Stock Information
- Founded
- SWBI 1852
- NPCE 1997
- Country
- SWBI United States
- NPCE United States
- Employees
- SWBI N/A
- NPCE N/A
- Industry
- SWBI Ordnance And Accessories
- NPCE Medical Specialities
- Sector
- SWBI Industrials
- NPCE Health Care
- Exchange
- SWBI Nasdaq
- NPCE Nasdaq
- Market Cap
- SWBI 429.0M
- NPCE 424.1M
- IPO Year
- SWBI N/A
- NPCE 2021
- Fundamental
- Price
- SWBI $8.54
- NPCE $9.94
- Analyst Decision
- SWBI Buy
- NPCE Buy
- Analyst Count
- SWBI 2
- NPCE 7
- Target Price
- SWBI $12.00
- NPCE $15.14
- AVG Volume (30 Days)
- SWBI 1.3M
- NPCE 411.2K
- Earning Date
- SWBI 09-04-2025
- NPCE 08-12-2025
- Dividend Yield
- SWBI 6.09%
- NPCE N/A
- EPS Growth
- SWBI N/A
- NPCE N/A
- EPS
- SWBI 0.30
- NPCE N/A
- Revenue
- SWBI $474,661,000.00
- NPCE $84,306,000.00
- Revenue This Year
- SWBI $8.53
- NPCE $21.04
- Revenue Next Year
- SWBI N/A
- NPCE $10.73
- P/E Ratio
- SWBI $28.47
- NPCE N/A
- Revenue Growth
- SWBI N/A
- NPCE 22.05
- 52 Week Low
- SWBI $8.38
- NPCE $5.45
- 52 Week High
- SWBI $16.85
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- SWBI 36.14
- NPCE 36.29
- Support Level
- SWBI $8.53
- NPCE $9.91
- Resistance Level
- SWBI $8.85
- NPCE $10.58
- Average True Range (ATR)
- SWBI 0.23
- NPCE 0.63
- MACD
- SWBI -0.04
- NPCE 0.03
- Stochastic Oscillator
- SWBI 20.54
- NPCE 19.29
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.